title: Idarucizumab for urgent reversal of dabigatran for heart transplant: A case report.
authors.affiliation: Department of Pharmacy Services, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Jessica
authors.identifier: http://orcid.org/0000-0001-6662-2302
authors.initials: J
authors.lastname: Rimsans
authors.affiliation: Department of Pharmacy Services, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Megan
authors.initials: M
authors.lastname: Rhoten
authors.affiliation: Department of Pharmacy Services, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Katelyn
authors.initials: K
authors.lastname: Sylvester
authors.affiliation: Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Steve K
authors.initials: SK
authors.lastname: Singh
authors.affiliation: Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Jean M
authors.initials: JM
authors.lastname: Connors
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D002311:Cardiomyopathy, Dilated / Q000503:physiopathology / Q000628:therapy*; D000069604:Dabigatran / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D008875:Middle Aged
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C000594745:idarucizumab; D000069604:Dabigatran